Skip to main content

Table 5 Secondary endpoint. Cardiovascular events, QCA measurements and quantitative OCT findings during the follow-up period

From: Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis

Cardiovascular events

ARB Group (n = 162)

Non-ARB Group (n = 245)

P value

Cardiovascular Events

 Non-fatal MI

3 (1.9%)

2 (0.8%)

0.354

 Cardiac death

1 (0.6%)

0

0.319

 Stroke

0

0

1.000

 TLR

25 (15.4%)

23 (9.4%)

0.077

QCA measurements

 Angiographic follow-up duration (months)

19.0 ± 11.4

20.3 ± 14.1

0.523

 RD (mm)

2.66 ± 0.30

2.68 ± 0.34

0.543

 MLD (mm)

2.24 ± 0.29

2.21 ± 0.27

0.648

 % stenosis

16 ± 8

19 ± 12

0.321

 Late lumen loss (mm)

0.29 ± 0.28

0.32 ± 0.36

0.196

 Binary restenosis

14 (8.6%)

22 (9.0%)

0.465

Quantitative OCT findings

 Mean lumen area, mm2

6.40 ± 2.49

6.74 ± 2.18

0.318

 Mean neointimal area, mm2

1.09 ± 1.00

1.38 ± 1.24

0.096

 Mean neointimal thickness, μm

140.6 ± 112.0

189.6 ± 423.1

0.217

 Malapposed strut No, %

0.70%

1.00%

0.322

 Exposed strut No, %

0.80%

1.10%

0.372

 Covered strut No, %

97.30%

92.60%

0.015

  1. MI myocardial infarction, TLR target lesion restenosis, QCA quantitative coronary angiography, RD reference diameter, MLD minimal lumen diameter, OCT optical coherence tomography, No numbers
  2. Values are expressed as mean ± SD for quantitative variables or as n (%) for qualitative variables